Sedation for children with metachromatic leukodystrophy undergoing MRI

Area of Science:

• Pediatric Anesthesiology
• Neuroimaging
• Lysosomal Storage Diseases

Background:

• Metachromatic leukodystrophy (MLD) is a rare genetic disorder impacting myelin, often requiring MRI for diagnosis.
• Procedural sedation is essential for pediatric MRI, yet limited data exists on MLD patients.
• Few case reports address anesthesia or sedation specifically for MLD patients.

Purpose of the Study:

• To evaluate the safety and efficacy of a sedation protocol for pediatric brain MRI in MLD patients.
• To compare sedative requirements between MLD patients and healthy children undergoing MRI.
• To establish best practices for sedating children with MLD for neuroimaging.

Main Methods:

• Prospective study of 18 MLD patients undergoing sedation for brain MRI.
• Comparison group of 20 healthy children (HLT) matched for age and undergoing MRI.
• Age-stratified sedation protocols using thiopental (≤3 years) or propofol (>3 years), with dose adjustments and complication monitoring.

Main Results:

• No sedation-related complications were observed in MLD patients.
• Mean thiopental doses for T_MLD and T_HLT groups were not significantly different.
• Mean propofol doses for P_MLD and P_HLT groups were comparable, showing no significant difference.

Conclusions:

• The established sedation protocol is safe and effective for pediatric MLD patients undergoing brain MRI.
• MLD patients do not necessitate different sedative dosages compared to their healthy counterparts.
• This study provides evidence supporting current sedation practices for MLD children in neuroimaging settings.